Product Program year 2025 Source: CMS Open Payments

LithoVue

Device LithoVue_URO

PDI 08714729874522

Open in the dashboard

General payments

$457,312

6,917 payments

Research payments

$14,430

4 payments

Through program year 2025, $457,312 in general payments and $14,430 in research payments were reported against LithoVue (LithoVue_URO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $90,033 1,698
2024 General $148,560 1,962
2024 Research $14,430 4
2023 General $115,197 1,889
2022 General $103,330 1,367
2021 General $193 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $457,312 6,917 payments
Top recipients General payments · program year 2025
  1. Bristol Whiles Urology · Kansas City, KS $1,600 2% · 1 payment
  2. Philip Zhao Urology · New York, NY $637 <1% · 7 payments
  3. William Atallah Urology · Brooklyn, NY $520 <1% · 6 payments
  4. Julie Riley Urology · Columbia, MO $487 <1% · 5 payments
  5. Amy Nemirovsky Urology · Baltimore, MD $482 <1% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $67,885 83% · 785 practitioners
  2. Physician Assistant $3,404 4% · 64 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $1,918 2% · 63 practitioners
  4. Nurse Practitioner $1,444 2% · 39 practitioners
  5. Pediatric Urology Urology $824 1% · 8 practitioners

The top 5 of 55 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Missouri $11,607 13% · 85 recipients
  2. Texas $8,331 9% · 122 recipients
  3. Florida $7,415 8% · 116 recipients
  4. California $6,836 8% · 78 recipients
  5. Utah $5,301 6% · 47 recipients

The top 5 of 47 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

6,917 general · 4 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record